Navigation Links
Mannatech Names New VP of Regulatory Affairs, Quality Assurance
Date:1/29/2008

Berkley brings more than 25 years of industry experience

COPPELL, Texas, Jan. 29 /PRNewswire-FirstCall/ -- Mannatech, Incorporated (Nasdaq: MTEX), a leading developer and provider of dietary supplements and skin care solutions, today announced the hiring of Marika Berkley as the company's vice president of global regulatory affairs and quality assurance.

"We are extremely pleased to announce Marika's addition to our management team," said Terry O'Day, executive vice president and COO of Mannatech. "Marika has a strong background in regulated health care industries in developing, implementing and maintaining quality systems used to achieve compliance with regulatory requirements. Her experience will be a valuable asset as we expand our international presence."

Having previously been the department head for the Quality Assurance and Regulatory Affairs disciplines, Berkley's experience includes directing all components of these functions, including strategic business development, ISO implementation, regulatory compliance, supply chain partnerships and auditing. In addition to her technical expertise, Berkley has vast experience in leading and developing teams, and in her own words, she is "particularly skilled in developing high performance interdisciplinary teams" -- something she looks forward to with the combining of the Quality Assurance and Regulatory Affairs departments.

Berkley's international experience includes Europe, Asia, Latin America and the Pacific Rim. Prior to joining Mannatech, Berkley worked for the Gillette Company, Abbott Labs and PFIZER Laboratories. Most recently, she was the Vice President of Quality Assurance and Regulatory Affairs for Facet Technologies, LLC, in Atlanta, Georgia.

Berkley graduated with a bachelor's of science degree in biology and chemistry from City University of New York.

About Mannatech

Mannatech, Incorporated, is a global wellness solutions provider of innovative, high-quality, proprietary nutritional supplements, topical and skin care products, and weight management products sold through independent associates and members located in the United States and the international markets of Canada, Australia, the United Kingdom, Japan, New Zealand, the Republic of Korea, Taiwan, Denmark, and Germany.

Please Note: This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as "intend" or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech's objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties, and other factors. Some of these factors include, among others, Mannatech's inability to attract and retain associates and members, increases in competition, litigation, regulatory changes, and its planned growth into new international markets. Although Mannatech believes that the expectations, statements, and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.

Contact Information:

Gary Spinell, Vice President

Investor Relations

972-471-6512

ir@mannatech.com

Corporate website: http://www.mannatech.com


'/>"/>
SOURCE Mannatech, Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Mannatech to Open Centralized-Management Office in Switzerland
2. Mannatech Hosts Australasian Convention
3. Mannatech Hosts Japan National Convention
4. Mannatech Launches Phase One of New Sales and Training Tools
5. AMERIGROUP Names Linda Whitley-Taylor as Executive Vice President, Associate Services
6. American Media, Inc. Names Dean Durbin Executive Vice President and Chief Financial Officer
7. Mount Diablo Region YMCA Names Local Business Leader, Susan Trainer, to Its Corporate Executive Board
8. Fleishman-Hillard Names FFI Global Cause for 2008
9. International Isotopes Inc. Names James Mayer as Chief Operating Officer
10. Bayer Corporation Renames Its U.S. Foundation, Refocuses Charitable Giving Areas
11. LearnSomething Names Deborah Faucette to New Position of Senior Vice President of Sales and Marketing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... ... ... James Earl Jones is known for myriad roles on stage and screen, he has ... the forthcoming episodes examines mammogram techniques; a very important part of preventative medicine. , ... detection. Like any other disease, treatments have a much higher chance of success if ...
(Date:12/4/2016)... CA (PRWEB) , ... December 04, 2016 , ... ... without undergoing major cosmetic surgery can now take advantage of a cosmetic procedure ... advanced skin rejuvenation treatment that reduces the appearance of age spots, fine ...
(Date:12/2/2016)... ... ... Lori G. Cohen and Sara K. Thompson , shareholders ... American Conference Institute’s 21st Drug & Medical Device Litigation Conference , taking place in ... , Cohen, who chairs the firm’s Pharmaceutical, Medical Device & Health Care Litigation Practice ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... ... across the Dothan-Wiregrass Area in Alabama are expected to attend the UNCF Dothan-Wiregrass ... will help provide scholarship funds for area students and operating support to UNCF-member ...
(Date:12/2/2016)... ... December 02, 2016 , ... The annual time frame ... (or Annual Election Period), is ending December 7th. Currently-enrolled Medicare beneficiaries who are looking ... prescription drug plan (Part D) need to make changes during this period order for ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... , December 2, 2016 bioLytical Laboratories, ein Weltführer ... bei den Mitgliedern des Apothekenbundes von Kenia eingeführt. ... ... INSTI HIV Self Test! (PRNewsFoto/bioLytical Laboratories) ...      (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) ...
(Date:12/2/2016)... , Dec. 2, 2016 Boston Scientific Corporation ... agreement to acquire certain manufacturing assets and capabilities of ... NVC) advanced biological tissue business, as well as a ... $75 million in cash. The Neovasc advanced biological tissue ... the Boston Scientific Lotus™ Valve System. * Upon ...
(Date:12/2/2016)... 2016 Lianluo Smart Limited (Nasdaq: ... which develops, markets and sells medical devices and ... and international markets, recently attended the ... New Progress Forum, co-hosted by the Institute of ... , Guangdong Provincial People,s Hospital and Cardiology Department ...
Breaking Medicine Technology: